Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria

被引:185
作者
Bolla, Jean-Michel [1 ,2 ]
Alibert-Franco, Sandrine [1 ,2 ,3 ]
Handzlik, Jadwiga [3 ,4 ]
Chevalier, Jacqueline [1 ,2 ]
Mahamoud, Abdallah [1 ,2 ]
Boyer, Gerard [1 ,2 ,5 ]
Kiec-Kononowicz, Katarzyna [3 ,4 ]
Pages, Jean-Marie [1 ,2 ,3 ]
机构
[1] Univ Mediterranee, Fac Med, UMR MD1, F-13385 Marseille 05, France
[2] Univ Mediterranee, Fac Pharm, UMR MD1, F-13385 Marseille 05, France
[3] COST Act BM0701 ATENS, Brusells, Belgium
[4] Jagiellonian Univ, Coll Med, Dept Technol & Biotechnol Drugs, Krakow, Poland
[5] Univ Paul Cezanne, UMR CNRS 6263, Marseille, France
关键词
Antibiotic; Bacterial efflux pump; Chemosensitizer; Drug transporter; Efflux pump inhibitor; Gram-negative bacteria; Lipopolysaccharide; MDR bacteria; Membrane permeability; Natural compound; Porin; Selectivity; EFFLUX PUMP INHIBITORS; ANTIMICROBIAL DRUG SUSCEPTIBILITY; 5-ARYLIDENE AROMATIC DERIVATIVES; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; ANTIMYCOBACTERIAL ACTIVITY; CRYSTAL-STRUCTURE; ACRB; MECHANISMS; 1-(1-NAPHTHYLMETHYL)-PIPERAZINE;
D O I
10.1016/j.febslet.2011.04.054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Gram-negative bacteria, the envelope is a sophisticated barrier protecting the cell against external toxic compounds. Membrane transporters, e. g., porins or efflux pumps, are main filters regulating the internal accumulation of various hydrophilic molecules. Regarding bacterial susceptibility towards antibacterial agents, membrane permeability is part of the early bacterial defense. The bacterium manages the translocation process, influx and efflux, to control the intracellular concentration of various molecules. Antibiotics and biocides are substrates of these mechanisms and the continuing emergence of multidrug resistant isolates is a growing worldwide health concern. Different strategies could be proposed to bypass the bacterial membrane barrier, comprising influx and efflux mechanisms, in order to restore the activity of antibiotics against resistant bacteria. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1682 / 1690
页数:9
相关论文
共 110 条
[1]  
Abeylath SC, 2008, EXPERT OPIN DRUG DEL, V5, P931, DOI [10.1517/17425247.5.9.931, 10.1517/17425247.5.9.931 ]
[2]   Molecular mechanisms of antibacterial multidrug resistance [J].
Alekshun, Michael N. ;
Levy, Stuart B. .
CELL, 2007, 128 (06) :1037-1050
[3]   New insights into the antibacterial mechanism of action of squalamine [J].
Alhanout, Kamel ;
Malesinki, Soazig ;
Vidal, Nicolas ;
Peyrot, Vincent ;
Rolain, Jean Marc ;
Brunel, Jean Michel .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (08) :1688-1693
[4]   Efflux Mechanism, an Attractive Target to Combat Multidrug Resistant Plasmodium falciparum and Pseudomonas aeruginosa [J].
Alibert-Franco, Sandrine ;
Pradines, Bruno ;
Mahamoud, Abdallah ;
Davin-Regli, Anne ;
Pages, Jean-Marie .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (03) :301-317
[5]   Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps [J].
Amaral, L. ;
Martins, M. ;
Viveiros, M. ;
Molnar, J. ;
Kristiansen, J. E. .
CURRENT DRUG TARGETS, 2008, 9 (09) :816-819
[6]  
Amaral Leonard, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P61
[7]   Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa [J].
Aoki, Nobumasa ;
Tateda, Kazuhiro ;
Kikuchi, Yoshiaki ;
Kimura, Soichiro ;
Miyazaki, Choichiroh ;
Ishii, Yoshikazu ;
Tanabe, Yoshinari ;
Gejyo, Fumitake ;
Yamaguchi, Keizo .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (03) :534-542
[8]   RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine [J].
Bailey, Andrew M. ;
Paulsen, Ian T. ;
Piddock, Laura J. V. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) :3604-3611
[9]   Measuring the impact of multidrug resistance in nosocomial infection [J].
Blot, Stijn ;
Depuydt, Pieter ;
Vandewoude, Koenraad ;
De Bacquer, Dirk .
CURRENT OPINION IN INFECTIOUS DISEASES, 2007, 20 (04) :391-396
[10]   Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps [J].
Bohnert, HA ;
Kern, WV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :849-852